Ferron G - Search Results

1

Watch and Wait Approach for Re-excision After Unplanned Yet Macroscopically Complete Excision of Extremity and Superficial Truncal Soft Tissue Sarcoma is Safe and Does Not Affect Metastatic Risk or Amputation Rate.

Decanter G, Stoeckle E, Honore C, Meeus P, Mattei JC, Dubray-Longeras P, Ferron G, Carrere S, Causeret S, Guilloit JM, Fau M, Rosset P, Machiavello JC, Delhorme JB, Regenet N, Gouin F, Blay JY, Coindre JM, Penel N, Bonvalot S. Decanter G, et al. Among authors: ferron g. Ann Surg Oncol. 2019 Oct;26(11):3526-3534. doi: 10.1245/s10434-019-07494-6. Epub 2019 Jul 23. Ann Surg Oncol. 2019. PMID: 31338771

2

Cost-effectiveness of intraperitoneal chemohyperthermia in the treatment of peritoneal carcinomatosis from colorectal cancer.

Bonastre J, Chevalier J, Elias D, Classe JM, Ferron G, Guilloit JM, Marchal F, Meeus P, De Pouvourville G. Bonastre J, et al. Among authors: ferron g. Value Health. 2008 May-Jun;11(3):347-53. doi: 10.1111/j.1524-4733.2007.00249.x. Value Health. 2008. PMID: 18489663 Free article.

3

Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.

Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe JM, Ferron G, Guilloit JM, Meeus P, Goéré D, Bonastre J. Elias D, et al. Among authors: ferron g. J Clin Oncol. 2009 Feb 10;27(5):681-5. doi: 10.1200/JCO.2008.19.7160. Epub 2008 Dec 22. J Clin Oncol. 2009. PMID: 19103728

4

Modified posterior pelvic exenteration for ovarian cancer.

Houvenaeghel G, Gutowski M, Buttarelli M, Cuisenier J, Narducci F, Dalle C, Ferron G, Morice P, Meeus P, Stockle E, Bannier M, Lambaudie E, Rouanet P, Fraisse J, Leblanc E, Dauplat J, Querleu D, Martel P, Castaigne D. Houvenaeghel G, et al. Among authors: ferron g. Int J Gynecol Cancer. 2009 Jul;19(5):968-73. doi: 10.1111/IGC.0b013e3181a7f38b. Int J Gynecol Cancer. 2009. PMID: 19574794

5

Oxaliplatin-based hyperthermic intraperitoneal chemotherapy in primary or recurrent epithelial ovarian cancer: A pilot study of 31 patients.

Frenel JS, Leux C, Pouplin L, Ferron G, Berton Rigaud D, Bourbouloux E, Dravet F, Jaffre I, Classe JM. Frenel JS, et al. Among authors: ferron g. J Surg Oncol. 2011 Jan 1;103(1):10-6. doi: 10.1002/jso.21732. J Surg Oncol. 2011. PMID: 21031424

6

Multi-center evaluation of post-operative morbidity and mortality after optimal cytoreductive surgery for advanced ovarian cancer.

Rafii A, Stoeckle E, Jean-Laurent M, Ferron G, Morice P, Houvenaeghel G, Lecuru F, Leblanc E, Querleu D. Rafii A, et al. Among authors: ferron g. PLoS One. 2012;7(7):e39415. doi: 10.1371/journal.pone.0039415. Epub 2012 Jul 23. PLoS One. 2012. PMID: 22844394 Free PMC article.

7

Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study.

Luyckx M, Leblanc E, Filleron T, Morice P, Darai E, Classe JM, Ferron G, Stoeckle E, Pomel C, Vinet B, Chereau E, Bergzoll C, Querleu D. Luyckx M, et al. Among authors: ferron g. Int J Gynecol Cancer. 2012 Oct;22(8):1337-43. doi: 10.1097/IGC.0b013e31826a3559. Int J Gynecol Cancer. 2012. PMID: 22964527

8

Survival benefit of hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer: a multi-institutional case control study.

Le Brun JF, Campion L, Berton-Rigaud D, Lorimier G, Marchal F, Ferron G, Oger AS, Dravet F, Jaffre I, Classe JM. Le Brun JF, et al. Among authors: ferron g. Ann Surg Oncol. 2014 Oct;21(11):3621-7. doi: 10.1245/s10434-014-3693-7. Epub 2014 May 13. Ann Surg Oncol. 2014. PMID: 24819120

9

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for First Relapse of Ovarian Cancer.

Classe JM, Glehen O, Decullier E, Bereder JM, Msika S, Lorimier G, Abboud K, Meeus P, Ferron G, Quenet F, Marchal F, Gouy S, Pomel C, Pocard M, Guyon F, Bakrin N; French Oncologic and Gynecologic HIPEC Group. Classe JM, et al. Among authors: ferron g. Anticancer Res. 2015 Sep;35(9):4997-5005. Anticancer Res. 2015. PMID: 26254399

10

Which Surgical Attitude to Choose in the Context of Non-Resectability of Ovarian Carcinomatosis: Beyond Gross Residual Disease Considerations.

Vidal F, Al Thani H, Haddad P, Luyckx M, Stoeckle E, Morice P, Leblanc E, Lecuru F, Daraï E, Classe JM, Pomel C, Mahfoud Z, Ferron G, Querleu D, Rafii A. Vidal F, et al. Among authors: ferron g. Ann Surg Oncol. 2016 Feb;23(2):434-42. doi: 10.1245/s10434-015-4890-8. Epub 2015 Nov 5. Ann Surg Oncol. 2016. PMID: 26542592

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters